Lindsey A Herrel (Lindsey Herrel)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 24

Top Topics

Health Insurance

Radical Prostatectomy

Prostate Cancer

Top Venues

Cancer medicine

JCO oncology practice

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Kassem S Faraj, Samuel R Kaufman, Mary Oerline, Lindsey A Herrel, Avinash Maganty, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The 340B Program and oral specialty drugs for advanced prostate cancer. Cancer 130 (12) (2024)
Kassem S Faraj, Samuel R Kaufman, Mary Oerline, Lindsey A Herrel, Avinash Maganty, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The 340B Program and oral specialty drugs for advanced prostate cancer. Cancer 130 (12) (2024)
Xinyu Liang, Ziwei Zhu, Kassem S Faraj, Vahakn B Shahinian, Brent K Hollenbeck, Lindsey A Herrel
Quality of care for dual eligible beneficiaries in the oncology care model. Cancer medicine 13 (14) (2024)
Rishi R Sekar, Avinash Maganty, Kristian D Stensland, Lindsey A Herrel
Association of Community-Level Social Vulnerability With Clinical Trial Discussion and Participation Among Cancer Survivors. JCO oncology practice (2024)
Kassem S Faraj, Samuel R Kaufman, Mary Oerline, Lindsey A Herrel, Avinash Maganty, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The 340B Program and oral specialty drugs for advanced prostate cancer. Cancer 130 (12) (2024)
Kassem S Faraj, Samuel R Kaufman, Mary Oerline, Lindsey A Herrel, Avinash Maganty, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The 340B Program and oral specialty drugs for advanced prostate cancer. Cancer 130 (12) (2024)
Xinyu Liang, Ziwei Zhu, Kassem S Faraj, Vahakn B Shahinian, Brent K Hollenbeck, Lindsey A Herrel
Quality of care for dual eligible beneficiaries in the oncology care model. Cancer medicine 13 (14) (2024)
Kassem S Faraj, Samuel R Kaufman, Mary Oerline, Lindsey A Herrel, Avinash Maganty, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The 340B Program and oral specialty drugs for advanced prostate cancer. Cancer (2024)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer 130 (9) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer 130 (9) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer 130 (9) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer 130 (9) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer 130 (9) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine 12 (24) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine 12 (24) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine 12 (24) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine 12 (24) (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary K Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer. Cancer (2023)
Kassem S Faraj, Samuel R Kaufman, Lindsey A Herrel, Avinash Maganty, Mary Oerline, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck
The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer. Cancer medicine 12 (24) (2023)
Anna Faris, Lindsey A Herrel, James M Weinberger, Stephanie Chisolm, Ashley Duby, Daniela A Wittmann
Urologic oncology patient perspectives during COVID-19 treatment delays. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (8) (2022)
Lindsey A Herrel, Ziwei Zhu, Andrew M Ryan, Brent K Hollenbeck, David C Miller
Intensity of end-of-life care for dual-eligible beneficiaries with cancer and the impact of delivery system affiliation. Cancer 127 (24) (2021)